VMP 42375711000001102

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Labetalol 100mg tablets
BNF code 0204000I0AAACAC
Virtual Therapeutic Moiety Labetalol
Date identifier became valid 27 Oct 2023
Previous product identifier 318445000
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units tablet
Unit dose unit of measure tablet
Virtual Product Ingredient
Ingredient Labetalol hydrochloride
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 100.000
Strength value numerator unit mg
Ontology Drug Form & Route
Form & Route tablet.oral
Dose Form
Formulation Oral tablet
Drug Route
Route Oral
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Labetalol 100mg tablets (A A H Pharmaceuticals Ltd)
Labetalol 100mg tablets (Alliance Healthcare (Distribution) Ltd)
Labetalol 100mg tablets (Medihealth (Northern) Ltd)
Labetalol 100mg tablets (Sigma Pharmaceuticals Plc)
Labetalol 100mg tablets (Tillomed Laboratories Ltd)
Labetalol 100mg tablets (Viatris UK Healthcare Ltd)
Trandate 100mg tablets (RPH Pharmaceuticals AB)
Virtual Medicinal Product Packs
Labetalol 100mg tablets 250 tablet
Labetalol 100mg tablets 56 tablet

dm+d data retrieved from TRUD: release NHSBSA_12.3.0_20241223000001, imported on 24th December 2024 at 03:51:32.

Feedback